PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters

Triple negative breast cancer (TNBC) is typically a high-grade breast cancer with poorest clinical outcome despite available treatment modalities with chemo-, immuno- and radiotherapy. The status of tumor-infiltrating lymphocytes (TILs) is a prognostic factor closely related to programmed death liga...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanowska, Olga, Kuczkiewicz-Siemion, Olga, Dębowska, Małgorzata, Olszewski, Wojciech P., Jagiełło-Gruszfeld, Agnieszka, Tysarowski, Andrzej, Prochorec-Sobieszek, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573147/
https://www.ncbi.nlm.nih.gov/pubmed/36233396
http://dx.doi.org/10.3390/jcm11195524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573147/
https://www.ncbi.nlm.nih.gov/pubmed/36233396
http://dx.doi.org/10.3390/jcm11195524

Ejemplares similares